Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 32,440

Document Document Title
WO/2018/006641A1
Provided is a traditional Chinese medicine for treating the edema caused by spleen deficiency with damp harassment in pregnant women. The traditional Chinese medicine is prepared by mixing the following raw materials in parts by weight: ...  
WO/2018/006642A1
Provided is a TCM drug for treating pregnant women suffering from spleen deficiency and dampness stagnation. The TCM drug consists of the following raw materials: 15-30 g of Radix scrophulariae, 10-25 g of Atractylodes macrocephala, 20-3...  
WO/2018/000665A1
Provided are an essential liquid for making breasts plump and firm and preventing breast diseases, and a method for preparing same, said essential liquid comprising: incense essential oil, rose essential oil, Pelargonium graveolens essen...  
WO/2018/003997A1
The present invention addresses the problem of providing a safe and easy-to-prepare cell preparation for prevention and/or treatment of organ fibrosis such as liver fibrosis. Provided is a cell preparation for prevention and/or treatment...  
WO/2017/223152A1
Embodiments of the present invention generally relate to methods for improving male fertility, and in particular for using sphingosine 1 phosphate (S I P) for improving the quality and/or longevity of sperm.  
WO/2017/210836A1
An herbal wine formulation for tonifying kidney and invigorating qi using Radix Asparagi and Radix Ginseng, prepared using the following ingredients in the corresponding weights: 30-50 g of Radix Asparagi; 42-50 g of Radix Ginseng; 15-20...  
WO/2017/214146A1
Methods and materials for treating bacterial vaginosis ("BV") are provided. Cervicovaginal secretions ("CVS") from a woman with vaginal microbiota dominated (>50%) by one of the species of lactobacillus typically found in the human vagin...  
WO/2017/210989A1
Disclosed are a phloroglucinol-oxytocin injection and a preparation method therefor. Each 10,000 ml injection contains 100 ml of an oxytocin solution and 0.2 g of phloroglucinol, and a 1 ml injection contains 10 units of the oxytocin sol...  
WO/2017/207481A1
The present application relates to the use of substituted indazoles for treatment and/or prophylaxis of allergic and/or inflammatory diseases in animals, especially for treatment and/or prophylaxis of atopic dermatitis, Flea Allergy Derm...  
WO/2017/207705A1
The invention relates to a La-1-like peptide agent that increases sperm motility. It is non-toxic and it may be used to treat male infertility in humans, and also to increase fertility in animals. It may be used in artificial reproductiv...  
WO/2017/203012A1
A compound which is (3R, 6R)-3-(2, 3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2, 6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S )-1-methylpropyl]-2,5-piperazinedione: (I) or a pharmaceutically acceptable salt thereof for use in th...  
WO/2017/201684A1
A combination of external medicines of an active ingredient I applied to a lesion and an active ingredient II applied to both sides of the chest. The active ingredient I consists of an immune protein powder and a traditional Chinese medi...  
WO/2017/204316A1
The present invention provides a novel compound having P2X3 and/or P2X2/3 receptor antagonism. A compound represented by formula (I): (wherein, R1 represents a substituted or unsubstituted alkyl or the like, R2 represents a substituted o...  
WO/2017/202817A1
The present invention covers [8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2, 3-triazol-4-yl)methanone compounds of general formula (I) in which R1, R2, R3, R4 and R5 are as defined herein, methods of preparing said compounds...  
WO/2017/200413A1
The present invention relates to the treatment of urogenital infectious diseases caused by pathogenic microorganisms. A pharmaceutical composition or compositions contain 3,3'-diindolylmethane (DIM) or a derivative thereof, alone or in c...  
WO/2017/201071A1
Pharmaceutical formulations containing a serotonin reuptake inhibitor and a smooth muscle relaxant are provided for the treatment of premature ejaculation and the increase in intravaginal ejaculatory latency time. Specific formulations c...  
WO/2017/197790A1
A Rhizoma Gastrodiae and Radix Morindae Officinalis liquor, consisting of components of: Rhizoma Gastrodiae: 35 g; Radix Morindae Officinalis: 60 g; Flos Chrysanthemi: 60 g; Radix Rehmanniae Preparata: 50 g; Fructus Lycii: 30 g; Zanthoxy...  
WO/2017/193509A1
Disclosed are a bionic gynecological lotion and a preparation method therefor. The lotion comprises a Musca domestica antibacterial peptide, a xylooligosaccharide, a xanthan gum and an artificial simulated vaginal secretion with a pH of ...  
WO/2017/195090A1
The present invention relates to follicular fluid for use in in vitro fertilization, where said use comprises introducing follicular fluid in the uterus in one or more administrations during a time period comprised between six days befor...  
WO/2017/190183A1
Provides herein are compositions for the treatment of chronic vulval or perineal pain, and of symptoms or conditions associated therewith, comprising an estrogen, optionally estriol, and a tricyclic antidepressant, optionally amitriptyli...  
WO/2017/192713A1
The present invention relates to nutritional compositions for mothers and methods for birth and post-partum outcomes for infants of those mothers. More particularly, the general inventive concepts relate to the administration of a nutrit...  
WO/2017/193000A1
A method is provided for treating a fatty acid oxidation metabolic condition, such as an inborn error of fatty acid oxidation or oxidative phosphorylation, and/or hypoglycemia, rhabdomyolysis, or cardiomyopathy in a patient. A mitochondr...  
WO/2017/192847A1
Described are novel female fertility therapies. A first aspect of the invention is directed to therapies that include FSH lowering methodologies to prevent and/or treat egg infertility. A second aspect of the invention is directed to age...  
WO/2017/192501A1
Disclosed are melanin compositions and devices, and methods of use thereof, to protect internal tissues and organs from radiation damage and to prevent or alleviate negative side effects associated with radiation exposure.  
WO/2017/192841A1
The invention provides methods of treatment and combination therapies using heterobicyclic and related compounds that activate Gcase, such as in the treatment of endometriosis and Parkinson's disease. An exemplary heterobicyclic compound...  
WO/2017/190107A1
Provided herein, inter alia, are compounds and methods of treating diseases including cancer, neurological disease, alcohol withdrawal, depression and anxiety, traumatic brain injury, and neuropathic pain.  
WO/2017/186088A1
Disclosed are multiple pharmaceutical usages of a small-molecule hyaluronic acid fragment, comprising: treating tumors, conjunctival diseases, xerophthalmia, vitreous opacitees, myofascitis, arthrolithiasis, cardiovascular diseases, cere...  
WO/2017/190109A1
Provided herein, inter alia, are compounds and methods of treating diseases including cancer, neurological disease, alcohol withdrawal, depression and anxiety, and neuropathic pain.  
WO/2017/181303A1
A method for preparing active ingredients of Eurycoma longifolia and a use thereof. The preparation method comprises the following steps: at a given temperature, extracting Eurycoma longifolia by means of countercurrent ultrasound to obt...  
WO/2017/179012A1
The present invention relates to a pharmaceutical or nutraceutical composition comprising at least one inositol and resveratrol for use in the a) preventive and/or curative treatment in the metabolic disorders related to polycystic ovary...  
WO/2017/180174A1
The present disclosure provides compositions and methods for making and using topical compositions comprised of an isotonic, biome-friendly solution containing xylose and/or a Salvia extract. The compositions are useful for, for example,...  
WO/2017/176938A1
In certain aspects, the present disclosure relates to the insight that a polypeptide comprising a ligand-binding portion of the extracellular domain of bone morphogenetic protein receptor type II (BMPRII) polypeptide binds to ligands inc...  
WO/2017/168174A1
The invention provides a pharmaceutical composition comprising sildenafil or a pharmaceutically acceptable salt thereof admixed with excipients in a multicomponent pharmaceutical composition, wherein a first component is adapted to deliv...  
WO/2017/170564A1
[Problem] To provide a novel DDS having SN-38 as the medicinal component. [Solution] An excellent SN-38 ester derivative with cancer cell proliferation inhibitory activity is provided which is effective in nanodrug production.  
WO/2017/170765A1
Provided are: a novel nitrogen-containing heterocyclic compound, which has an aldosterone synthase-inhibiting activity and, therefore, is useful for preventing and/or treating various diseases or symptoms associated with aldosterone and/...  
WO/2017/163216A1
The present invention relates to a pharmaceutical composition or a composition for a medical device or a composition for a food supplement (briefly, the composition (s) of the present invention) based on lactic acid bacteria belonging to...  
WO/2017/163217A1
The present invention relates to a pharmaceutical composition or a composition for a medical device or a composition for a food supplement (briefly, the composition (s) of the present invention) based on lactic acid bacteria belonging to...  
WO/2017/161427A1
The present invention relates to a method for producing hybrid or non-hybrid recombinant glycoprotein hormones, for example the recombinant equine chorionic gonadotropin (r-eCG), the hybrid recombinant chorionic gonadotropin, the recombi...  
WO/2017/162770A1
The invention relates to a product, in particular a nutritional supplement, animal feed, foodstuff, drug, cosmetic and/or animal feed supplement for supplying at least one molecule that bonds to a vitamin D receptor, in particular a calc...  
WO/2017/161222A1
The invention is for methods and compositions for blocking calcium- activated channels in uterine smooth muscle tissue which in turn inhibits or blocks uterine contractions leading to preterm labor. This methods and compositions are usef...  
WO/2017/157260A1
Provided are a phenylpropanoid and a preparation method and application thereof. The phenylpropanoid has a structure represented by formula (I), and a pharmaceutically acceptable salt thereof has a structure represented by formula (II) o...  
WO/2017/153608A1
The invention relates to a zona pellucida (ZP) protein or peptide for use in preventing the increase of the number of animals in an animal population, to the use of a ZP protein or peptide in order to prevent the increase of the number o...  
WO/2017/154865A1
The present invention provides an ameliorating agent for a female-specific physical and/or mental unpleasant symptom, which comprises γ-tocopherol and/or equol.  
WO/2017/148975A1
The present invention relates to a composition comprising, as an antifungal agent, at least 2.1010 CFUs of Lactobacillus, and a sulphur compound, for use as a first line treatment for candidiasis infections and recurring candidiasis infe...  
WO/2017/144925A1
The present invention relates to a topical composition which is mixture of natural ingredients of plant and animal origin, to the process of its preparation, to its use for treatment and/or prophylaxis of mastitis and/or edema in female ...  
WO/2017/144393A1
The invention relates to bromodomain-protein-inhibiting, in particular BET-protein-inhibiting, and preferably BRD4-inhibiting 2-substituted 5-(phenyl)-1,2-dihydro-3H-3-benzazepine-3-carboxamide derivatives of general formula (I), where R...  
WO/2017/137535A1
The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): (I) and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3- kinase...  
WO/2017/139603A1
The present application relates to certain halo-substituted piperidine compounds, pharmaceutical compositions containing them, and methods of using them, including methods for treating substance addiction, panic disorder, anxiety, post-t...  
WO/2017/133337A1
The present invention provides a substituted benzimidazolone compound and a composition comprising the same. The present invention discloses a substituted benzimidazolone compound represented by formula (I) and a pharmaceutical compositi...  
WO/2017/135805A1
The present invention relates to a composition made from extracts of ginger (Zingiber officinale), clove (Syzygium aromaticum), green tea (Camelia sinensis), pot marigold (Calendula officinalis), broccoli (Brassica oleracea italica) and ...  

Matches 1 - 50 out of 32,440